Literature DB >> 11254958

Characterization of the Trypanosoma cruzi Cdc2p-related protein kinase 1 and identification of three novel associating cyclins.

E B Gómez1, M I Santori, S Laría, J C Engel, J Swindle, H Eisen, P Szankasi, M T Téllez-Iñón.   

Abstract

Several Cdc2p-related protein kinases (CRKs) have been described in trypanosomatids but their role in the control of the cell cycle nor their biological functions have been addressed. In Trypanosoma cruzi two CRKs have been identified, TzCRK1 and TzCRK3. In this work we further characterize T. cruzi CRK1 and report the identification of three novel associating cyclins. We demonstrate that CRK1 levels and localization do not vary during the cell cycle, and show that it is localized in the cytoplasm, discrete regions of the nucleus, and is highly concentrated in the mitochondrion DNA (kinetoplast), suggesting a putative control function in this organelle. Using purified anti-CRK1 IgGs, we immunoprecipitated from the soluble fraction of T. cruzi epimastigote forms a protein kinase activity which is not inhibited by CDK inhibitors. In addition, we co-precipitated with p13Suc1p beads a kinase activity that was inhibited by the CDK inhibitor flavopiridol and olomoucine. Lastly, using the yeast two-hybrid system we identified three novel cyclin-like proteins able to associate with TzCRK1, and demonstrate that two of these cyclins also bind the T. cruzi CRK3 protein, indicating that these two CRKs are cyclin-dependent kinases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254958     DOI: 10.1016/s0166-6851(00)00382-0

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Pairwise knockdowns of cdc2-related kinases (CRKs) in Trypanosoma brucei identified the CRKs for G1/S and G2/M transitions and demonstrated distinctive cytokinetic regulations between two developmental stages of the organism.

Authors:  Xiaoming Tu; Ching C Wang
Journal:  Eukaryot Cell       Date:  2005-04

Review 2.  Protein kinases as drug targets in trypanosomes and Leishmania.

Authors:  Christina Naula; Marilyn Parsons; Jeremy C Mottram
Journal:  Biochim Biophys Acta       Date:  2005-09-08

3.  Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi.

Authors:  Yi Bao; Louis M Weiss; Yan Fen Ma; Stuart Kahn; Huan Huang
Journal:  Microbes Infect       Date:  2010-05-11       Impact factor: 2.700

4.  Coupling of posterior cytoskeletal morphogenesis to the G1/S transition in the Trypanosoma brucei cell cycle.

Authors:  Xiaoming Tu; Ching C Wang
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

5.  The Role of Heme and Reactive Oxygen Species in Proliferation and Survival of Trypanosoma cruzi.

Authors:  Marcia Cristina Paes; Daniela Cosentino-Gomes; Cíntia Fernandes de Souza; Natália Pereira de Almeida Nogueira; José Roberto Meyer-Fernandes
Journal:  J Parasitol Res       Date:  2011-10-09

6.  The Trypanosoma cruzi nucleic acid binding protein Tc38 presents changes in the intramitochondrial distribution during the cell cycle.

Authors:  María A Duhagon; Lucía Pastro; José R Sotelo-Silveira; Leticia Pérez-Díaz; Dante Maugeri; Sheila C Nardelli; Sergio Schenkman; Noreen Williams; Bruno Dallagiovanna; Beatriz Garat
Journal:  BMC Microbiol       Date:  2009-02-11       Impact factor: 3.605

7.  Transcriptome-wide analysis of the Trypanosoma cruzi proliferative cycle identifies the periodically expressed mRNAs and their multiple levels of control.

Authors:  Santiago Chávez; Guillermo Eastman; Pablo Smircich; Lorena Lourdes Becco; Carolina Oliveira-Rizzo; Rafael Fort; Mariana Potenza; Beatriz Garat; José Roberto Sotelo-Silveira; María Ana Duhagon
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

8.  Extensive Translational Regulation through the Proliferative Transition of Trypanosoma cruzi Revealed by Multi-Omics.

Authors:  Santiago Chávez; Michael D Urbaniak; Corinna Benz; Pablo Smircich; Beatriz Garat; José R Sotelo-Silveira; María Ana Duhagon
Journal:  mSphere       Date:  2021-09-01       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.